Variable Annuity Life Insurance Co Updates Annuity Fees
Variable Annuity Life Insurance Co Separate Account A updates its prospectus to reflect new fees and expenses for annuity contracts, impacting the investment landscape.
Innovator ETFs Trust Files New Prospectus for ETF Product
Innovator ETFs Trust updates its prospectus for the Innovator U.S. Equity Ultra Buffer ETF, emphasizing defined outcome strategies for investors.
Innovator ETFs Trust updates prospectus for equity buffer ETF
Innovator ETFs Trust has filed a new prospectus for its Innovator U.S. Equity Buffer ETF, effective November 2, 2026, reflecting its commitment to defined outcome strategies.
TIM S.A. Plans Incorporation of I-Systems Solutions
TIM S.A. announces the proposed incorporation of I-Systems, enhancing its capabilities in the telecommunications sector.
Rithm Capital Corp. Reports Q3 2026 Financial Results
Rithm Capital Corp. releases its Q3 2026 financial results, showcasing performance in the real estate investment sector.
Andrew Pieper Files Ownership Report for Offerpad Shares
Andrew Pieper files a Form 3 detailing his ownership in Offerpad Solutions Inc., highlighting his role as Interim CFO and stock holdings.
Fakhoury Ranni Emad Reports 5.02% Stake in SenesTech
Fakhoury Ranni Emad has disclosed a 5.02% ownership in SenesTech, Inc., signaling potential strategic interests in the agriculture chemicals sector.
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Richard B. Handler, CEO of Jefferies Financial Group, reports stock transactions reflecting estate planning, as detailed in a recent SEC filing.
Brophy Michael Burkes sells 3,084 shares of Natera stock
Brophy Michael Burkes, CFO of Natera, Inc., sold 3,084 shares of common stock, signaling adjustments in executive holdings and compliance in the medical sector.
JANA Partners cuts stake in Alkami Technology below 5%
JANA Partners Management, LP reduces its stake in Alkami Technology, Inc., allowing for flexible discussions with the board. Details revealed in SEC filing.
Powell Anderson Capital Partners Amends Stake in Franklin Street
Powell Anderson Capital Partners LLC amends its Schedule 13D, revealing an 8.0% stake in Franklin Street Properties Corp, enhancing its influence in the REIT sector.
Glenbrook Capital Management Boosts Stake in SenesTech
Glenbrook Capital Management increases its stake in SenesTech, acquiring 30,000 shares, signaling confidence in the agricultural chemicals sector.
Glenbrook Capital Management Increases Stake in SenesTech
Glenbrook Capital Management now holds over 40% of SenesTech, signaling potential strategic shifts in the agricultural chemicals sector.
MediaAlpha updates ownership stake in Schedule 13D/A filing
MediaAlpha, Inc. updates its Schedule 13D/A, revealing a 35.1% ownership stake by White Mountains Insurance Group and WM Hinson.
SB Global Advisers Amends Schedule 13D for VTEX Stake
SB Global Advisers Ltd has increased its stake in VTEX to 42.9%, as revealed in a recent SEC filing, impacting the prepackaged software industry.
Chuang Hao-Yuan acquires 5,000 shares in Belite Bio, Inc.
Chuang Hao-Yuan has acquired 5,000 shares in Belite Bio, Inc. as part of a stock award, signaling executive commitment in the pharmaceutical sector.
OS Therapies grants stock options to Chief Medical Officer
OS Therapies Inc grants stock options to CMO Robert Petit, highlighting its commitment to key personnel in the competitive pharmaceutical industry.
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Lin Yu-Hsin, CEO of Belite Bio, vests 5,000 shares after meeting performance criteria, highlighting executive compensation trends in the pharmaceutical sector.
Chen Wan-Shan Reports Share Transaction for Belite Bio
Chen Wan-Shan disclosed a transaction involving 13,796 shares of Belite Bio, reflecting active engagement in the pharmaceutical sector.
Clem Kerry M Reports 300,000 Stock Options in SEC Filing
Clem Kerry M, Chief Commercial Officer of OS Therapies, reports 300,000 stock options in SEC filing, highlighting executive incentives and growth potential.